What is the current France In-Vitro Diagnostics Market size?

The France In-Vitro Diagnostics Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029) Read More

Who are the key players in France In-Vitro Diagnostics Market?

Thermo Fischer Scientific Inc, QIAGEN N.V., Siemens Healthcare GmbH, F. Hoffmann-La Roche AG and Abbott Laboratories are the major companies operating in the France In-Vitro Diagnostics Market. Read More

What years does this France In-Vitro Diagnostics Market cover?

The report covers the France In-Vitro Diagnostics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the France In-Vitro Diagnostics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

France In-Vitro Diagnostics Market Share

Statistics for the 2023 & 2024 France In-Vitro Diagnostics market share, created by Mordor Intelligence™ Industry Reports. France In-Vitro Diagnostics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of France In-Vitro Diagnostics Industry

France is a developed region with a well-structured healthcare system. As a result, many players in the in-vitro diagnostics market are present in the country. Thus, the in-vitro diagnostic market in France is fairly fragmented, with the presence of local players competing in the market. Some of the players in the market include Abbott Laboratories, F. Hoffmann-La Roche AG, QIAGEN N.V., Siemens Healthineers AG, Thermo Fischer Scientific Inc., BioMerieux and Becton, Dickinson and Company.